PSMAfore: A phase 3 study to compare (177)Lu-PSMA-617 treatment with a change in androgen receptor pathway inhibitor in taxane-naïve patients with metastatic castration-resistant prostate cancer Meeting Abstract
| Authors: | Sartor, A. O.; Morris, M. J.; Chi, K. N.; De Bono, J. S.; Shore, N. D.; Crosby, M.; Kreisl, T. N.; Fizazi, K. |
| Abstract Title: | PSMAfore: A phase 3 study to compare (177)Lu-PSMA-617 treatment with a change in androgen receptor pathway inhibitor in taxane-naïve patients with metastatic castration-resistant prostate cancer |
| Meeting Title: | 2022 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2022 Feb 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-20 |
| Language: | English |
| ACCESSION: | WOS:000771008900216 |
| DOI: | 10.1200/JCO.2022.40.6_suppl.TPS211 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS211 -- Meeting was conducted online as well as in person -- Source: Wos |
